LENSAR (LNSR) Stock: Buy, Sell, or Hold?
LNSR - LENSAR, Inc. Common Stock
$6.88
-0.04 (-0.58%)
▼
5d:
-4.58%
30d:
-18.68%
90d:
+20.28%
HOLD
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LNSR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LNSR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: LNSR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: LNSR is currently trading at $6.88, which is considered oversold relative to its 30-day fair value range of $7.22 to $8.64. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.7) compared to its historical average (14.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNSR is in a strong uptrend. The price is currently testing key support at $6.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNSR scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+67.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LNSR is in a strong uptrend. The price is currently testing key support at $6.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNSR scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+67.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.22 -
$8.64
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.2% below Wall St target ($11.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 26% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$7.22 -
$8.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.79
Resistance Level
$7.92
Current Trend
Strong Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.69
Wall Street Target
$11.50
(+67.2%)
Revenue Growth (YoY)
18.4%
Profit Margin
57.6%
PE vs Historical
-9.7 vs 14.6
CHEAP
Share & Embed Analysis
Last updated: September 29, 2026 8:46 AM ET
Data refreshes hourly during market hours. Next update: 9:45 AM
Data refreshes hourly during market hours. Next update: 9:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNSR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 72 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 44 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 55 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 54 HOLD |
